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Frequently, clinicians confront situations that a pile of 
cumulated data about a disease does not help them to make 
clear decision. Cervical adenocarcinoma in situ (AIS) is one of 
them. It has been commonly believed that the disease has 
multifocal location and this raised the concern for the safety of 
conservative management in treatment of cervical AIS. Thus, 
even with negative conization margins, many recommend 
further surgery in fear of a risk of residual or recurrent disease. 
However, due to its relatively lower incidence than its 
counterpart, many studies regarding of outcome of AIS are 
small-sized and retrospective, which limited their usefulness 
as an evidence for decision-making evidence.
In this issue of Journal of Gynecologic Oncology, Kim et al. [1] 
reported the retrospective observational data of 99 women 
with AIS in single institution. Despite its retrospective nature, 
the study provides helpful insight of the disease and is one of 
the large-scale observational sets currently available. The most 
intriguing data in the study were the incidence of residual 
margin and recurrence data of AIS with negative margin. The 
authors found the residual disease only in 4.4% of patients 
who underwent further surgery. On the other hand, they also 
found the 3.6% of recurrence rate in the AIS patients who 
received conservative management, which was corresponds 
well to the pathologic outcome of surgically managed cases. 
The good correspondence between incidence rate of residual 
lesion and the recurrence rate is very interesting, especially in 
light of recent systemic review by Salani et al. [2]. In the report, 
the authors estimated the recurrence rate as 2.6% in the 
conservatively-managed patients, which is well corresponds 
to the study by Kim et al.
However, the estimated incidence of residual disease in 
the hysterectomy specimen was as much as 20.3%, which 
is evidently higher than that of data presented by Kim et al. 
This discrepancy is not surprising. First, in the systemic review, 
the authors included many case reports. Many case reports 
reported the disastrous outcome of conservative expectation 
after conization when the margin was negative. Therefore, it 
can be serious source of bias exaggerating the incidence of 
failure in margin-negative patients. Indeed, simple application 
of random-effect model in the previous systemic review, we 
can easily found that the incidence decreased to 15%. On 
the other hand, in the Kim’s data, selection bias might have 
influenced and decreased the incidence of conization failure 
in margin-negative patients because clinicians would advise 
hysterectomy more frequently in the patient with higher 
risk. Despite the discrepancy of rate of residual disease, the 
good correspondence of recurrence rate of margin-negative 
patients between two studies (2.6% and 3.6%, respectively) 
gave us important insight for selecting treatment strategy 
because the known recurrence rate of cervical carcinoma in 
situ is about 2% [3,4].
For the patients with margin-negative AIS, what treatment 
strategy can be drawn from these data? First, it is evident that 
margin-negative young patients who want to preserve their 
fertility can be treated with conservative expectation. Second, 
the collective evidences suggests that margin-negative 
patients should be given with the choice to select between 
decisive hysterectomy and conservative expectation with 
careful follow-up, even they do not wish to retain fertility. 
Adequate information including warning for the chance 
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of residual disease and low incidence of recurrence rate 
should be provided through patient counseling. However, 
considering subsequent rate of residual disease and limited 
accuracy in surveillance technique, definite hysterectomy still 
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